Accordingly, DAPK promoter hypermethylation can therefore be used as an indicator of tumor progression in NSCLC cases, which means that DAPK methylation may have a significant correlation with the prognostic feature of NSCLC as well as the origin of NSCLC.119, 123. The gene discussed is DAPK1; the disease is neoplasm.